Expanding CAR-T Cell Technology to Diverse Therapeutic Applications

This inventive concept leverages the core technology of CAR-T cells with TCM as the main active component to develop novel therapeutic solutions for neurodegenerative diseases, cancer relapse, autoimmune disorders, and personalized cancer vaccines.

The original patent disclosed a method for preparing CAR-T cells with TCM as the main active component, primarily focused on cancer treatment. However, the limitations of this technology lie in its narrow application scope. This inventive concept addresses the problem of limited therapeutic applications by exploring the potential of CAR-T cells with TCM in diverse fields.

The new claims expand the original patent's technology to four distinct areas: (1) treating neurodegenerative diseases by targeting specific disease antigens, (2) reducing cancer relapse in leukemia patients through long-term immune response induction, (3) detecting cancer biomarkers using engineered CAR-T cells, and (4) treating autoimmune disorders by inducing regulatory immune responses. Each application involves engineering CAR-T cells with TCM to recognize specific antigens or biomarkers, thereby inducing therapeutic responses.

The novelty of this inventive concept lies in the unexpected application of CAR-T cells with TCM to neurodegenerative diseases, cancer relapse, autoimmune disorders, and personalized cancer vaccines. The inventive step involves the recognition of the versatility of CAR-T cells with TCM and their potential to address unmet needs in diverse therapeutic areas.

Alternative embodiments of this inventive concept could include modifying the CAR-T cell's antigen recognition capabilities, using different types of T cells, or combining CAR-T cells with other immunotherapies. Variations may also involve adapting the technology to address specific disease subtypes or patient populations.

This inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, with potential applications in neurodegenerative disease treatment, cancer therapy, autoimmune disorder management, and personalized medicine. The market for these applications is substantial, with growing demands for innovative therapeutic solutions.